Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
|
|
CHINA JO-JO DRUGSTORES, INC. (CJJD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/28/2021 |
8-K
| Quarterly results |
| 07/20/2021 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 07/01/2021 |
8-K
| Quarterly results |
| 05/14/2021 |
8-K
| Quarterly results |
| 04/22/2021 |
8-K
| Quarterly results |
| 02/12/2021 |
8-K
| Quarterly results |
| 12/23/2020 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 11/13/2020 |
8-K
| Quarterly results|
Docs:
|
"China Jo-Jo Drugstores Reports Second Quarter 2021 Financial Results HANGZHOU, China, November 13, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the second fiscal quarter ended September 30, 2020. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, “We are pleased with our second quarter performance as we delivered another quarter of strong results. Our revenue and gross profit recorded $30.84 million and $7.01 million for the second fiscal quarter of 2021, up 8.8% and 4.8% compared to same period of fiscal year 2020. Revenue year-over-year from online pharmacy increased by 127.4%. We have al..." |
|
| 10/29/2020 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 10/22/2020 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
| 08/14/2020 |
8-K
| Quarterly results |
| 07/10/2020 |
8-K
| Quarterly results |
| 06/26/2020 |
8-K
| Other Events |
| 06/15/2020 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/03/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering HANGZHOU, China, June 3, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it closed its previously announced registered direct offering with certain institutional investors for an aggregate of 5,000,004 shares of the common stock, at a purchase price of $2.00 per share, for aggregate gross proceeds of approximately $10 million to the Company. In a concurrent private placement, the Company issued to the same investors unregistered warrants to purchase up to an aggregate of 3,750,003 shares of the common stock at an exercise price of $2.60 pe..." |
|
| 06/02/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits |
| 03/09/2020 |
8-K
| Quarterly results |
| 02/14/2020 |
8-K
| Quarterly results |
| 11/14/2019 |
8-K
| Quarterly results |
| 08/14/2019 |
8-K
| Quarterly results|
Docs:
|
"China Jo-Jo Drugstores Reports First Quarter 2020 Financial Results HANGZHOU, China, August 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced its financial results for the first quarter of its fiscal year 2020. Mr. Lei Liu, Chief Executive Officer and Chairman of Jo-Jo Drugstores, commented, “We are pleased to announce our financial results for the first quarter of fiscal year 2020. Our sales grew 11.0%, with sales growth in our retail drugstores, online pharmacy, and wholesale segments. We will continue adapting to the changing retail drugstore environment and making progress towards our long-term strategic goals. We rema..." |
|
| 07/01/2019 |
8-K
| Quarterly results|
Docs:
|
"China Jo-Jo Drugstores Reports Fiscal Year 2019 Financial Results HANGZHOU, China, July 1, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2019. Mr. Lei Liu, Chairman and Chief Executive Officer of China Jo-Jo Drugstores, Inc., commented, “We are pleased to present our financial results for our 2019 fiscal year. We increased our top line revenue to $107.55 million for the 2019 fiscal year as compared to $96.11 million for the previous fiscal year. Over the course of the 2019 fiscal year we made great strides in improving our operations and made a key senior appointmen..." |
|
| 04/22/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 04/15/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering HANGZHOU, China, April 15, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it closed a registered direct offering with several institutional investors for an aggregate of 4,000,008 shares of the common stock, at a purchase price of $2.50 per share, for aggregate gross proceeds of approximately $10 million to the Company. In a concurrent private placement, the Company issued to the investors unregistered warrants to purchase up to an aggregate of 3,000,006 shares of the common stock at an exercise price of $3.00 per share. The warrants shal..." |
|
| 04/12/2019 |
8-K/A
| Quarterly results |
| 04/11/2019 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits|
Docs:
|
"Form of Common Stock Purchase Warrant",
"Form of Securities Purchase Agreement",
"Engagement Agreement",
"China Jo-Jo Drugstores Announces $10 Million Registered Direct Offering HANGZHOU, China, April 11, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with several institutional investors providing for the issuance of 4,000,008 shares of common stock, at a purchase price of $2.50 per share, in a registered direct offering for aggregate gross proceeds of approximately $10.0 million. Jo-Jo Drugstores also agreed to issue to the investors unregistered warrants to purchase up to 3,000,006 shares of common stock. The closing of the sale of the securities is expected to take place on or about ..." |
|
| 03/13/2019 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 03/04/2019 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 02/14/2019 |
8-K
| Quarterly results |
| 11/14/2018 |
8-K
| Quarterly results|
Docs:
|
"China Jo-Jo Drugstores Reports Second Quarter 2019 Financial Results HANGZHOU, China, November 14, 2018 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced its financial results for its second fiscal quarter, ended September 30, 2018. Mr. Lei Liu, Chief Executive Officer and Chairman of Jo-Jo Drugstores, commented, “We are pleased to report our financial results for the second quarter of our 2019 fiscal year. Our revenue grew 16.7% compared to the same period of the previous year as we continued to grow our retail drugstore and wholesale businesses. In the coming quarters we are excited to attempt to improve our online offerings, imp..." |
|
| 11/09/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/26/2018 |
8-K
| Quarterly results |
| 09/06/2018 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/14/2018 |
8-K
| Quarterly results|
Docs:
|
"China Jo-Jo Drugstores Reports First Quarter 2019 Financial Results HANGZHOU, China, Aug. 14, 2018 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced its financial results for the first quarter ended June 30, 2018. Mr. Lei Liu, Chief Executive Officer and Chairman of Jo-Jo Drugstores, Inc., commented, “We continue to emphasize our retail strategy as we report our first quarter results for fiscal year 2019. Our gross margin for retail drug stores for the first quarter was 30.1%, up from 25.2% from the same period last year, as we emphasized increasing profit margins, introducing new suppliers, and renegotiating prices with our suppli..." |
|
| 06/29/2018 |
8-K
| Quarterly results|
Docs:
|
"China Jo-Jo Drugstores Reports Fiscal Year 2018 Financial Results HANGZHOU, China, Jun. 29, 2018 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. , a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2018. Mr. Lei Liu, Chief Executive Officer and Chairman of Jo-Jo Drugstores, Inc., commented, “Fiscal year 2018 has been an important transition year for China Jo-Jo Drugstores with revenues increased by 17.9% year-over-year to $96.11 million. We expanded our retail business, opening 55 new retail drugstores in key locations, and continued to improve services in our existing stores. While our e-commerce business continued its tran..." |
|
|
|
|